RNA-binding protein ptbp1 regulates alternative splicing and transcriptome in spermatogonia and maintains spermatogenesis in concert with nanos3 by Senoo, Manami et al.
Title
RNA-binding protein ptbp1 regulates alternative
splicing and transcriptome in spermatogonia and
maintains spermatogenesis in concert with nanos3
Author(s)
Senoo, Manami; Hozoji, Hiroshi; Ishikawa-
Yamauchi, Yu; Takijiri, Takashi; Ohta, Sho;
Ukai, Tomoyo; Kabata, Mio; Yamamoto, Takuya;
Yamada, Yasuhiro; Ikawa, Masahito; Ozawa, Manabu














RNA-binding protein Ptbp1 regulates alternative splicing and 
transcriptome in spermatogonia and maintains spermatogenesis in 
concert with Nanos3
Manami SENOO1, 2), Hiroshi HOZOJI1, 2), Yu ISHIKAWA-YAMAUCHI1), Takashi TAKIJIRI1, 2), 
Sho OHTA3), Tomoyo UKAI3), Mio KABATA4), Takuya YAMAMOTO4–7), Yasuhiro YAMADA3), 
Masahito IKAWA1, 8) and Manabu OZAWA1)
1)Laboratory of Reproductive Systems Biology, Center for Experimental Medicine and Systems Biology,  
The Institute of Medical Science, The University of Tokyo, Tokyo 108-8639, Japan
2)Graduate School of Frontier Sciences, The University of Tokyo, Tokyo 108-8639, Japan
3)Division of Stem Cell Pathology, Center for Experimental Medicine and Systems Biology, Institute of Medical Science, 
University of Tokyo, Tokyo 108-8639, Japan
4)Department of Life Science Frontiers, Center for iPS Cell Research and Application (CiRA), Kyoto University,  
Kyoto 606-8507, Japan
5)Institute for the Advanced Study of Human Biology (WPI-ASHBi), Kyoto University, Kyoto 606-8501, Japan
6)AMED-CREST, Tokyo 100-0004, Japan
7)Medical-risk Avoidance based on iPS Cells Team, RIKEN Center for Advanced Intelligence Project (AIP),  
Kyoto 606-8507, Japan
8)Research Institute for Microbial Diseases, Osaka University, Osaka 565-0871, Japan
Abstract.  PTBP1, a well-conserved RNA-binding protein, regulates cellular development by tuning posttranscriptional 
mRNA modification such as alternative splicing (AS) or mRNA stabilization. We previously revealed that the loss of Ptbp1 
in spermatogonia causes the dysregulation of spermatogenesis, but the molecular mechanisms by which PTBP1 regulates 
spermatogonium homeostasis are unclear. In this study, changes of AS or transcriptome in Ptbp1-knockout (KO) germline stem 
cells (GSC), an in vitro model of proliferating spermatogonia, was determined by next generation sequencing. We identified 
more than 200 differentially expressed genes, as well as 85 genes with altered AS due to the loss of PTBP1. Surprisingly, no 
differentially expressed genes overlapped with different AS genes in Ptbp1-KO GSC. In addition, we observed that the mRNA 
expression of Nanos3, an essential gene for normal spermatogenesis, was significantly decreased in Ptbp1-KO spermatogonia. 
We also revealed that PTBP1 protein binds to Nanos3 mRNA in spermatogonia. Furthermore, Nanos3+/−;Ptbp1+/− mice 
exhibited abnormal spermatogenesis, which resembled the effects of germ cell-specific Ptbp1 KO, whereas no significant 
abnormality was observed in mice heterozygous for either gene alone. These data implied that PTBP1 regulates alternative 
splicing and transcriptome in spermatogonia under different molecular pathways, and contributes spermatogenesis, at least in 
part, in concert with NANOS3.
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 (J. Reprod. Dev. 66: 459–467, 2020) 
In male mammals, spermatogenesis, a highly orchestrated process to produce mature sperm, is sustained throughout life under the strict 
control of various molecular mechanisms [1–3]. Recent advancements 
in sequencing technology have led to the discovery that testes rank 
among the top tissues concerning transcriptome complexity and 
alternative splicing (AS) [4–7]. AS changes RNA isoforms drastically 
in accordance with testicular germ cell differentiation from mitotic 
spermatogonia to meiotic spermatocytes to haploid spermatids [4, 
7]. AS is a mechanism for producing multiple gene products from 
a single gene locus using different combinations of coding or non-
coding exons, thereby increasing the diversity of the transcriptome 
and proteome and facilitating proper tissue development [8, 9]. In 
humans, more than 90% of genes have splicing isoforms [10].
RNA-binding proteins (RBPs) play a central role in posttran-
scriptional RNA modification such as AS or RNA stabilization 
and organizes tissue development and homeostasis [6, 11]. The 
polypyrimidine tract-binding proteins (PTBPs) are highly conserved 
RBPs from Caenorhabditis elegans to mammals, and they have been 
implicated in many aspects of mRNA regulation including AS [12], 
polyadenylation [13], and stabilization [14]. In testes, two paralog 
genes of the PTBP family are expressed, e.g., PTBP1 and PTBP2, 
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and these genes display stage-specific expression differences in 
testes. PTBP1 is mainly expressed by mitotic spermatogonia, and 
its expression is diminished by differentiation after the spermatocyte 
stage. Conversely, PTBP2 is hardly expressed by spermatogonia, 
whereas its expression becomes evident in meiotic spermatocytes [15]. 
Germ cell-specific loss of PTBP2 has little effect on transcriptomic 
regulation or AS in spermatogonia, whereas it drastically alters 
stage-specific changes in transcriptomic regulation or AS from 
spermatogonia to spermatocytes, resulting in the dysregulation of 
spermatogenesis after meiosis [6, 7]. We previously developed a 
spermatogonium-specific Ptbp1 conditional knockout model (Ptbp1 
cKO) and observed its phenotypic feature; that is, Ptbp1 cKO animals 
exhibited an increased number of seminiferous tubules exhibit-
ing degeneration of spermatogenesis accompanied by the slower 
proliferation of spermatogonia [16]. These previous results including 
ours suggest that the stage-specific regulation of the transcriptome 
or AS by PTBP family proteins plays an important role in normal 
spermatogenesis. However, the PTBP1-mediated regulation of the 
transcriptome or AS in spermatogonia has not been fully clarified.
In this study, we assessed the alteration of transcriptomic regula-
tion and AS in cultured spermatogonia, i.e., germline stem cells 
(GSCs), lacking PTBP1 using next-generation sequencing (NGS). 
We demonstrated that 276 genes were differentially expressed in 
Ptbp1 cKO GSCs compared with their control levels. In addition, 
103 different AS isoforms of 85 genes were detected. It is notable 
that none of the differentially expressed genes overlapped with 
genes with different AS isoforms. We also observed using wild-
type GSCs that PTBP1 protein binds to Nanos3, an essential factor 
for normal spermatogenesis [17], and Nanos3 mRNA expression 
was decreased in Ptbp1 cKO GSCs. Strikingly, mice heterozygous 
for both PTBP1 and NANOS3 exhibited an increased number of 
seminiferous tubules displaying degeneration of spermatogenesis, 
the genotypic features of which resemble germ cell-specific Ptbp1 
cKO mice [16]. Contrarily, heterozygous deletion of either gene 
alone did not result in significant abnormality of spermatogenesis. 
Collectively, our present data indicated an important role of PTBP1 
in regulating the transcriptome and AS in spermatogonia and that the 
PTBP1-mediated regulation of spermatogenesis might act, at least 
in part, in concert with the function of NANOS3.
Materials and Methods
Animals and ethics
Mice were maintained under pathogen-free conditions in the 
experimental animal facility at the Institute of Medical Science of 
the University of Tokyo. All mouse experiments were approved 
by the Institutional Animal Care and Use Committee of the 
University of Tokyo (approval number PA17-64) and performed in 
compliance with their guidelines. C57BL/6J mice were purchased 
from Japan SLC (Shizuoka, Japan). Ptbp1flox and Ptbp1+/− mice 
[18] as well as CAG-CreMer mice [19] were established in our 
laboratory via a conventional targeting strategy using 129-strain 
embryonic stem cells and backcrossed at least 10 times with 
C57BL/6J mice. Nanos3-Cre-pA (Nanos3+/−, ICR congenic) [17] 
and Gt(ROSA)26Sortm4(ACTB-tdTomato,-EGFP)Luo (mTmG) mice were 
obtained from RIKEN BRC and the Jackson Laboratory, respectively.
GSC development
mTmG;CAG-CreMer;Ptbp1flox/flox (Ptbp1-FF) or wild-type mice 
(BDF1 background) were used for GSC development according to a 
previously reported method [20]. In brief, the testes of 7–10-day-old 
postpartum neonates were collected and digested into single cells 
enzymatically. Single cells were seeded onto mitotically inactivated 
feeder cells (X-ray-irradiated or mitomycin C-treated mouse embry-
onic fibroblasts) in GSC culture medium with a slight modification. 
Specifically, 2 mM GlutaMax and 5 mg/ml AlbuMax II (both from 
Thermo Fisher Scientific, Waltham, MA, USA) were added to the 
medium instead of 2 mM l-glutamine and 5 mg/ml bovine serum 
albumin, respectively [21], and cells were cultured at 37°C in a 
humid atmosphere of 5% CO2 to develop stably self-renewing GSCs. 
GSCs were passaged every 7–10 days at a density of 2 × 105 cells/
ml. To initiate the tamoxifen-induced deletion of the floxed allele in 
Ptbp1-FF GSCs, 1 μM 4-hydroxitamoxifen (4OHT, LKT Laboratories, 
St. Paul, MN, USA) was added to the culture medium.
RNA-seq
Total RNA was extracted from GSCs using NucleoSpin RNA 
II or NucleoSpin RNA Plus (Macherey-Nagel, Düren, Germany) 
according to the manufacturer’s instructions (DNase treatment was 
included in the RNA extraction procedure in this kit). RNA-seq 
libraries were generated using a Truseq Stranded mRNA samples 
prep kit (Illumina, San Diego, CA, USA). The resulting RNA-seq 
libraries were generated using single-ended sequencing at a length 
of 86 bp on a NextSeq 500 (Illumina). RNA-seq reads were mapped 
to the mouse reference genome (mm10) using STAR version 2.5.3a 
with the GENCODE version M17 annotation gtf file after trimming 
adaptor sequences and bases with low-quality values using cutadapt 
version 1.16 [22]. Fragments per kilobase of exon per million mapped 
reads (FPKM) values were calculated as the expression levels of 
each gene using cufflinks-2.2.1 [23] with the mouse GENCODE 
(version M17, protein coding) annotation gtf file. For the splicing 
analysis, RNA-seq reads crossing exon-exon junctions were used to 
calculate inclusion ratios as described previously [24] and identify 
the alternatively spliced exons via statistical analysis (Fisher’s exact 
test using a 2 × 2 table in which junction reads were divided by cell 
types, i.e.. control versus cKO, and read types, i.e., inclusion versus 
exclusion) followed by multiple-test correction with a false discovery 
rate (Benjamini–Hochberg FDR) of less than 0.05. The calculation of 
the inclusion ratio, the statistical analysis, and the clustering analysis 
were performed using R software with custom-made scripts. All the 
RNA-seq data are available in SRA (Bio- Project: PRJNA623420).
Quantitative real-time PCR (qPCR) and reverse transcription 
PCR (RT-PCR)
The primers used in this study are shown in Table 1. Total RNA was 
extracted from GSCs as described in the “RNA-seq” section. cDNA 
was synthesized using SuperScript VILO (Thermo Fisher Scientific) 
according to the manufacturer’s instructions in a reaction volume 
of 10 µl. The synthesized cDNA was used for qPCR or RT-PCR. 
Taq DNA-polymerase Standard (Greiner Bio-One, Tokyo, Japan) 
was used for RT-PCR. Amplified DNA was visualized using Novel 
Juice (Bio-Helix, Keelung City, Taiwan, ROC), and signals were 
detected using BluPAD (LM, Tokyo, Japan). For qPCR analysis, 
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Thunderbird SYBR qPCR Mix (Toyobo, Osaka, Japan) and StepOne 
system (Thermo Fisher Scientific) were used for quantification. The 
fold difference was calculated using the ΔΔCt method [25].
Histological analysis
Testes were fixed in PBS containing 4% (v/v) paraformaldehyde 
(PBS-PFA) overnight at 4°C and then dehydrated by serial treatment 
with gradient ethanol solutions (from 70 to 100% [v/v] ethanol). 
Thereafter, dehydrated testes were embedded in paraffin for sectioning 
at a thickness of 5 μm. For histological staining, sections were 
deparaffinized in Lemosol A (FUJIFILM Wako Pure Chemical, Tokyo, 
Japan), rehydrated by serial treatment with gradient ethanol solutions 
(from 100 to 70% [v/v] ethanol), washed in water, and stained with 
hematoxylin and eosin staining. Slides were covered by a coverslip 
with Mount-Quick mounting medium (Daido Sangyo, Tokyo, Japan) 
and observed using a microscope (BZ-X700, Keyence, Osaka, Japan).
Immunohistochemistry
For immunohistochemistry, testes were fixed in PBS-PFA overnight 
at 4°C, dehydrated, embedded in paraffin, and sectioned as described 
previously. Rehydrated sections were boiled in Tris-EDTA buffer 
(10 mM Tris, 1 mM EDTA, and 0.05% [v/v] Tween-20 prepared 
in water, pH 9.0) via autoclaving (120°C, 20 min) to reactivate 
antigens. Sections were then permeabilized with 0.3% (v/v) Triton 
X diluted in Tris-buffered saline and blocked using 1% (w/v) bovine 
serum albumin (Nacalai Tesque, Kyoto, Japan) and 10% normal goat 
serum (Jackson ImmunoResearch, West Grove, PA, USA) at room 
temperature for 1 h. Slides were incubated with primary antibodies 
(rabbit anti-PLZF (1:100, sc-22839, Santa Cruz Biotechnology, Dallas, 
TX, USA), anti-SCP3 (1:500, Santa Cruz), rat anti-germ cell-specific 
nuclear antigen (GENA; clone TRA98, BioAcademia, Osaka, Japan), 
or anti-TRA54 antibodies (1:100, Abcam, Cambridge, MA, USA)) 
at 4°C overnight with gentle shaking. Then, sections were incubated 
with Alexa Fluor 488-, 555-, or 647-conjugated host species-specific 
secondary antibodies (all from Thermo Fisher Scientific) for 1 h at 
room temperature in the dark. After antibody exposure, sections 
were incubated with 0.1% (w/v) Sudan black B (Sigma-Aldrich, 
St. Louis, MO, USA) solution to quench autofluorescence signals. 
Then, sections were mounted on a coverslip with anti-fade mounting 
solution containing NucBlue nuclei staining dye (ProLong Glass; 
Thermo Fisher Scientific). Fluorescence signals were detected using 
a fluorescence microscope (BZ-X700).
RNA immunoprecipitation (RNA-IP)
RNA-IP using wild-type GSC lysate was performed using an 
RIP assay kit (MBL Life Science, Nagoya, Japan) according to the 
manufacturer’s instructions. Mouse anti-PTBP1 (15 µg of antibody 
in 30 µl of reaction mixture, #324800, Thermo Fisher Scientific) 
or normal mouse IgG (negative control, #5415S, Cell Signaling 
Technology, Danvers, MA, USA) was used for IP. Immunoprecipitated 
protein and RNA were analyzed using standard Western blotting or 
RT-PCR protocols, respectively. Protein bands were visualized using 
Luminata Forte (Merck Millipore, Tokyo, Japan), and signals were 
detected using the ChemiDoc Imaging System (Bio-Rad, Hercules, 
CA, USA).
Statistical analysis
All numerical data are presented as the mean ± SEM. Differences 
between genotypes were tested using Student’s t-test. P values less 
than 0.05 were considered significant.
Results
PTBP1 is required for the regulation of AS in GSCs
Undifferentiated spermatogonia can self-renew in culture via 
stimulation of GDNF and FGF2 while retaining their stem/progenitor 
characteristics [20]. We utilized this culture system to investigate 
whether PTBP1 regulates AS in spermatogonia by performing RNA-
seq. In this study, 4OHT was administered to induce the deletion of 
PTBP1 in Ptbp1-FF GSCs (Ptbp1 cKO), and the solvent (ethanol)-
administered group was designated as the control. Ptbp1 mRNA 
expression, which was visualized using Integrative Genomics Viewer 
(https://software.broadinstitute.org/software/igv/), was absent in 
Ptbp1 cKO GSCs, whereas the mRNA expression of the adjacent 
Plppr3 gene was comparable between control and Ptbp1 cKO GSCs, 
indicating that our inducible Ptbp1 cKO GSC model worked properly 
(Fig. 1A). Ptbp1 cKO GSCs displayed severe growth defects in vitro 
(Fig. 1B), as we have reported previously [16]. RNA-seq reads, which 
spanned exon splice junction sites, were used to analyze the splicing 
pattern [26]. The pattern was categorized into six different types of 
AS, e.g., “skipped exon,” “mutually exclusive exon,” “alternative 5′ 
splice site,” “alternative 3′ splice site,” “alternative first exon,” and 
“alternative last exon,” by comparing the “inclusion ratio,” which 
was defined as the ratio of the number of reads derived from the 
“inclusion (red-lined splicing)” junction region to the total number of 
Table 1. PCR primers
Method Gene Forward Reverse
qPCR Ptbp1 GGTCTCTTCCGTGTGCCATG CTGCGCTCCTGTTGTCACCT
Nanos3 CACTACGGCCTAGGAGCTTGG TGATCGCTGACAAGACTGTGGC
Gapdh ATGAATACGGCTACAGCAACAGG CTCTTGCTCAGTGTCCTTGCTG




qPCR, quantitative real-time PCR; RT-PCR, reverse transcription PCR.
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reads derived from the inclusion and “exclusion (blue-lined splicing)” 
junction regions (Fig. 1C) as reported previously [24]. One hundred 
three different splicing events (in 85 genes) exhibited inclusion ratios 
that significantly differed (FDR < 0.05) between control and Ptbp1 
cKO GSCs by a minimum absolute change of 0.2 (Fig. 1C). Three 
independent genes with different splicing isoforms as determined 
via RNA-seq analysis were selected to confirm the AS changes by 
RT-PCR (Fig. 1D). Notably, changes in “skipped exon” events, 
especially exon inclusion, were most evident after the deletion of 
PTBP1 in GSCs (Fig. 1C, left up panel). These observations implied 
that PTBP1 is required for AS in the spermatogonia and that the 
main role of PTBP1 in AS is to regulate cassette exon exclusion.
Alteration of the transcriptome in Ptbp1-deleted GSC
Next, we investigated the alteration of global mRNA expression 
patterns in Ptbp1 cKO GSCs. By using > 2- or < 0.5-fold changes as 
the cut-offs, a total of 276 genes displayed different expression levels 
(163 upregulated and 113 downregulated genes) between Ptbp1 cKO 
and control GSCs (Fig. 2A). Interestingly, no differentially expressed 
genes between Ptbp1 cKO and control GSCs exhibited featured 
different AS isoforms. We plotted the FPKM values of 85 differentially 
spliced genes, and they displayed strong concordance (R = 0.97) 
between the Ptbp1 cKO and control GSCs (Fig. 2B), suggesting that 
PTBP1 controls either AS or mRNA expression, whereas the regula-
tion machinery might be independent. To analyze which biological 
processes are relevant to the changes in the transcriptome of Ptbp1 
cKO GSCs, differentially expressed genes were examined via Gene 
Ontology (GO) analysis using Database for Annotation, Visualization 
and Integrated Discovery (DAVID; DAVID Bioinformatics Resources 
6.8, https://david.ncifcrf.gov) [27]. Regarding genes upregulated 
in Ptbp1 cKO GSCs, 12 GO terms were enriched (cut-off of P < 
0.05), including two terms related to cell death or cell proliferation 
retardation, e.g., p53 signaling pathway and regulation of apoptotic 
process (Fig. 2C). The term ‘p53 signaling pathway’ contained Casp8, 
Bcl3, Pax8, Card11, Agtr2, and Phlpp1, and the term ‘regulation 
of apoptotic process’ contained Perp, Adgrb1, Steap3, and Casp8. 
Concerning genes downregulated in Ptbp1 cKO GSCs, nine GO terms 
were listed. Interestingly, Nanos3, which is known as an essential 
factor for germ cell development or spermatogenesis [28, 29], was 
included under the GO terms ‘cell differentiation’ and ‘multicellular 
organism development’ (Fig. 2D).
PTBP1 protein binds to Nanos3 mRNA
Our RNA-seq analysis revealed that Nanos3 mRNA expression 
is downregulated in Ptbp1 cKO GSCs compared with the control 
levels (Fig. 3A). Thus, we next analyzed to confirm Nanos3 mRNA 
reduction using qPCR. Nanos3 mRNA expression was significantly 
decreased in Ptbp1 cKO GSCs, and the extent of downregulation was 
comparable with that in RNA-seq analysis (Fig. 3B). PTPB1 is an 
RBP that regulates posttranscriptional RNA processing, such as AS 
and polyadenylation, to ensure RNA stability. Thus, we next attempted 
to confirm whether PTBP1 protein binds to Nanos3 mRNA by RNA-
immunoprecipitation (RNA-IP) using anti-PTBP1 antibody followed 
by RT-PCR. PTBP1 protein was specifically immunoprecipitated by 
anti-PTBP1 antibody (Fig. 3C), and Nanos3 mRNA was detected 
in the anti-PTBP1–immunoprecipitated ribonucleoprotein samples 
(Fig. 3D). These results clearly demonstrated that PTBP1 binds to 
Nanos3 mRNA, thus indicating the co-regulatory roles of PTBP1 
and NANOS3 in spermatogonia.
Ptbp1 and Nanos3 double heterozygous deletion results in 
abnormal spermatogenesis in mice
The results from the present analysis led us to hypothesize that 
PTBP1 maintains the proliferation of spermatogonia in concert with 
NANOS3. Our previous paper reported that approximately 20% of 
seminiferous tubules display degeneration of spermatogenesis, i.e., 
tubules with no germ cells, in spermatogonium-specific Ptbp1 cKO 
models [16]. Conversely, conventional Ptbp1 knockout (KO) is em-
bryonically lethal around gastrulation [29], and conventional Nanos3 
KO results in complete infertility because of a defect in primordial 
germ cell development [17]. Therefore, we developed the Ptbp1 and 
Nanos3 double heterozygous deletion mouse (Nanos3+/−;Ptbp1+/−) 
to assess the roles of these genes in spermatogenesis. Weight of the 
testis did not differ significantly at 5 weeks old (Fig. 4A). At that age, 
almost all seminiferous tubules exhibited normal spermatogenesis 
in the Nanos3+/− or Ptbp1+/− testis. By contrast, significantly more 
seminiferous tubules exhibited degeneration of spermatogenesis in the 
Nanos3+/−;Ptbp1+/− testis (Fig. 4B, asterisk). Immunohistochemistry 
revealed that many degenerated seminiferous tubules did not contain 
germ cells including spermatogonia (PLZF+), spermatocytes (SCP3+), 
and spermatids (TRA54+, Fig. 4C). The proportions of seminiferous 
tubules exhibiting degeneration of spermatogenesis were less than 
1% in three of four Nanos3+/− mice and all four Ptbp1+/− mice, and 
the percentage was less than 2.5% in the fourth Nanos3+/− mouse. 
Conversely, the ratios exceeded 5% in three of five Nanos3+/−;Ptbp1+/− 
mice, with the highest proportion being 31.1% in one mouse (Fig. 
4D). These results suggest that the additive effect of PTBP1 and 
NANOS3 plays an important role in normal spermatogenesis.
Discussion
In this study, we examined the roles of PTBP1, a highly conserved 
RBP that is strongly expressed by spermatogonia, in global AS and 
transcriptomic regulation in spermatogonia. For this purpose, we 
conducted RNA-seq analysis using Ptbp1 cKO GSCs and identified 
more than 200 differentially expressed genes, as well as 85 genes 
Fig. 1. Polypyrimidine tract-binding protein 1 (PTBP1) is required for regulation of alternative splicing in germline stem cells (GSCs). (A) RNA-seq 
reads revealing the loss of Ptbp1 mRNA expression in Ptbp1 conditional knockout (cKO) GSCs. (B) Representative morphology of control 
(upper panel) and Ptbp1 cKO GSCs (lower panel). (C) Scatter plots present the inclusion ratios of Ptbp1 cKO and control GSCs. Each dot 
indicates a splicing event whose inclusion ratio was changed by more than 0.5-fold (red and blue) or 0.2–0.5-fold (orange and light-blue) 
(Fisher’s exact test, false discovery rate < 0.01). The numbers of the dot in color in each fraction are shown. (D) RNA-seq reads of Cers5, 
Dpf2, and H13 revealing that alternative exons are highly retained in Ptbp1 cKO GSCs (left panels). Different alternative splicing patterns were 
confirmed by reverse transcription-PCR (right panels).
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with altered AS due to the loss of PTBP1. We also confirmed that 
PTBP1 protein binds to Nanos3 mRNA, an essential gene for normal 
spermatogenesis [17], and its mRNA expression is downregulated in 
Ptbp1 cKO GSCs. In addition, mice featuring heterozygous deletion 
of both Ptbp1 and Nanos3 (Nanos3+/−;Ptbp1+/−) exhibits an increased 
number of seminiferous tubules displaying degeneration of spermato-
genesis, in line with the findings in germ cell-specific Ptbp1 cKO mice, 
whereas mice with heterozygous for either gene alone (Nanos3+/− or 
Ptbp1+/−) did not exhibit significant abnormal spermatogenesis. Taken 
together, our present data indicate the important roles of PTBP1 in 
transcriptomic regulation and AS in spermatogonia. Furthermore, 
although further analysis to determine PTBP1 or NANOS3 expres-
sions in the Nanos3+/−;Ptbp1+/− spermatogonia will be needed in the 
future experiment, the present results imply that PTBP1 regulates 
spermatogenesis, at least in part, in concert with NANOS3 function.
PTBP1 is a highly conserved RBP that is known to control cellular 
differentiation or specification by regulating the posttranscriptional 
modification of immature mRNAs. For example, PTBP1 governs 
the differentiation of neural progenitor cells to ependymal cells 
[30] or neurons by regulating AS of cell type-specific exons [31]. 
PTBP1 is also essential for the differentiation of immature B-cells to 
antigen-producing mature B-cells [32]. Our recent data using germ 
cell-specific Ptbp1 cKO uncovered that this gene plays an important 
role in normal spermatogenesis, especially in the proliferation of 
spermatogonia [16]. This is in agreement with our present findings 
that the deletion of Ptbp1 from cultured GSCs results in a drastic 
decrease in cell proliferation.
PTBP1 is known to regulate AS mainly via exon skipping by 
binding to the polypyrimidine-rich intronic region of nascent RNAs 
[33]. Along these lines, we detected that ‘exon skipping’ was most 
commonly altered in Ptbp1 cKO GSCs. Interestingly, the expression of 
genes with different AS isoforms in Ptbp1 cKO GSC was comparable 
with that in the control cells, and the correlation was strong (R = 
0.97). In addition, no genes featuring AS isoforms overlapped with 
differentially expressed genes between Ptbp1 cKO and control 
GSCs. Germ cell-specific cKO of PTBP2, a homolog of PTBP1 with 
highly overlapping target genes [34], also resulted in drastic changes 
in the AS isoforms of a number of genes in the testes, whereas the 
FPKM values of the different AS genes were comparable with high 
correlation rates (R2 = 0.93) with the findings in the WT control [7]. 
Therefore, PTBP1 might govern AS or transcriptomic regulation 
under different molecular pathways.
NANOS3 is another RBP that has essential roles in spermatogen-
esis; e.g., NANOS3 regulates primordial germ cell (PGC) development 
Fig. 2. Alteration of transcriptome in polypyrimidine tract-binding protein 1 (Ptbp1)-deleted germline stem cells (GSCs). (A) Heatmap revealing the 
levels of differentially expressed genes (276 genes) in Ptbp1 conditional knockout (cKO) GSCs. (B) Comparison of fragments per kilobase of 
exon per million mapped reads (FPKM) values for the 85 genes with significantly different alternative splicing isoforms between Ptbp1 cKO and 
control GSCs. (C and D) Gene Ontology (GO) analysis of upregulated (C) and downregulated genes (D) in Ptbp1 cKO GSCs (cut-off of 2-fold). 
DAVID Bioinformatics Resources 6.8 was used for the analysis, and significantly enriched GO terms are listed (P < 0.05).
Fig. 3. Polypyrimidine tract-binding protein 1 (PTBP1) protein binds to Nanos3 mRNA. (A) Fragments per kilobase of exon per million mapped reads 
(FPKM) values of Ptbp1 and Nanos3 are shown in the left and right panels, respectively. (B) The reduction of Nanos3 mRNA expression in Ptbp1 
conditional knockout germline stem cells (GSCs) was also confirmed by quantitative real-time PCR. Asterisks indicate a significant difference 
(** P < 0.01; n = 3). (C) Immunoblotting of PTBP1 (upper panel) or pan-ACTIN (bottom panel) following immunoprecipitation by an anti-
PTBP1 antibody or IgG-conjugated microbeads using wild-type GSC lysate. (D) mRNA was extracted from anti-PTBP1–immunoprecipitated 
GSC lysate and analyzed by reverse transcription-PCR using a Nanos3-specific primer set.
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[17] or maintains cell cycles of spermatogonia [35], and male Nanos3 
KO mice are infertile [17]. Nanos3 mRNA is expressed by PGC 
as early as E9.5 embryo, then disappear after E14.5 [28]. Nanos3 
expression is reactivated and maintained in spermatogonia after 
birth [28]. We observed that PTBP1 protein is expressed by PGC 
as early as E12.5 (data not shown), and fetal testis of PGC-specific 
Nanos3-Ptbp1 double hetero deletion (Nanos3+/Cre-KI; Ptbp1+/flox 
mouse in which floxed allele was removed only in PGC by Cre 
recombinase driven by Nanos3 promoter) does not exhibit significant 
abnormality (Supplementary Fig. 1: online only). Therefore, it suggests 
that abnormal spermatogenesis observed in this study occurs after 
spermatogenesis begins.
Although the AS isoforms of Nanos3 mRNA did not differ between 
Ptbp1 cKO and control GSCs, mRNA expression was significantly 
downregulated in Ptbp1 cKO cells. Another important role of PTBP1 
in addition to AS regulation is for regulating mRNA stability. For 
example, PTBP1 binds to 3’-untranslated region (UTR) of Cd154 
mRNA [36, 37], or 5’-UTR of Axl mRNA [38], and protects from 
immature degradation of mRNAs. Using wild-type GSC, we clearly 
found that PTBP1 binds to Nanos3 mRNA, suggesting that PTBP1 has 
regulatory roles in Nanos3 mRNA modification including maintenance 
of mRNA stability. Nanos3 KO resulted in a significant increase in 
apoptotic cell death in germ cells [17]. Increased apoptosis is also 
observed in Ptbp1 cKO models [16], and the GO analysis in the 
present study revealed that the term ‘regulation of apoptotic process’ 
was significantly enriched in Ptbp1 cKO GSCs. Strikingly, our in 
vivo Nanos3+/−;Ptbp1+/− displayed an increase in the degeneration 
of spermatogenesis, and the phenotypic feature were similar to 
those of Ptbp1 cKO mice [16], although intensity of the phenotype 
in Nanos3+/−;Ptbp1+/− varies among individual males. One possible 
explanation of this phenotypic variation is that mice used in this study 
have mixed genetic background. Nanos3+/– is ICR-backcrossed strain, 
and Ptbp1+/– is F2-F4 generation of ICR-B6 mixed. We mated these 
animals to make Nanos3+/;Ptbp1+/– mutant. These mixed background 
Fig. 4. Heterozygous deletion of both polypyrimidine tract-binding protein 1 (Ptbp1) and Nanos3 results in abnormal spermatogenesis in mice. (A) Testis 
weight of mice in each genotype at 5-week of age (Nanos3+/− and Ptbp1+/−, n = 4; Nanos3+/−;Ptbp1+/−, n = 5). (B) Hematoxylin and eosin staining 
of testes from Nanos3+/− (left), Ptbp1+/− (middle), and Nanos3+/−;Ptbp1+/− mice (right). The asterisk denotes seminiferous tubules exhibiting 
degeneration of spermatogenesis. Scale bar denotes 100 µm. (C) Immunohistochemical analysis of the testicular germ cell distribution in different 
stages of spermatogenesis in Nanos3+/− (left), Ptbp1+/− (middle), or Nanos3+/−;Ptbp1+/− mice (right). Sections were stained with anti-PLZF (a 
marker of spermatogonia), anti-SCP3 (a marker of spermatocytes), and TRA54 (a marker of haploid spermatids). Nuclei were stained with 
NucBlue. Scale bar denotes 100 µm. (D) Ratio of seminiferous tubules displaying degeneration of spermatogenesis in each genotype. Each dot 
represents the number in each mouse, and the bar represents the average (Nanos3+/− and Ptbp1+/−, n = 4; Nanos3+/−;Ptbp1+/−, n = 5).
REGULATION OF SPERMATOGENESIS BY PTBP1 467
in each individual, especially in Nanos3+/;Ptbp1+/– mutant, might be 
a cause of the variation. Collectively, although detailed mechanisms 
remain to be elucidated, the PTBP1-mediated regulation of sper-
matogenesis might occur, at least in part, in concert with NANOS3 
function. Further study to determine relations of Ptbp1 and Nanos3 
on spermatogenesis, e.g., transgenic-rescue of Nanos3 in the Ptbp1 
null spermatogonia will be needed.
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